Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Altreno (IDP-121) in Acne Vulgaris
NCT02491060Phase 3Unknown
- Sponsor
- Bausch Health
- Start
- Sep 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tretinoin in acne vulgaris, sponsored by Bausch Health. Status: unknown.
02
Drugs
tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02491060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02491060.